DEDIFFERENTIATED PROGRAMMED STEM CELLS OF MONOCYTIC ORIGIN, THEIR OBTAINING AND APPLICATION Russian patent published in 2008 - IPC C12N5/08 A61K35/12 A61L27/38 A61P41/00 A61P43/00 

Abstract RU 2333243 C2

FIELD: medicine.

SUBSTANCE: invention concerns biotechnology and can be applied in obtaining grown-up dedifferentiated programmed stem cells from human monocytes. Monocytes are cultivated in cultural medium containing M-CSF and IL-3. Obtained dedifferentiated programmed stem cells are applied in production of pharmaceutical compositions, target cells and tissues.

EFFECT: method of fast and easy obtaining safe material for substitution cell therapy.

39 cl, 25 dwg, 13 ex

Similar patents RU2333243C2

Title Year Author Number
CELLS AS PRECURSORS OF HUMAN LIVER 2000
  • Rejd Lola M.
  • Kubota Khirosi
  • Moss Nikolas
RU2247565C2
STEM CELL PRODUCED FROM HUMAN MONOCYTE AND USED FOR THERAPEUTIC APPLICATION AND METHOD FOR INDUCING IT 2009
  • Khirano Khisanobu
  • Okhkubo Jasusi
  • Sasaki Kendziro
  • Isijama Khironobu
RU2573906C2
METHOD FOR ISOLATION OF PLURIPOTENT STEM CELLS FROM UMBILICAL BLOOD EXPRESSING ZNF281 2010
  • Kang Kiung Sun
  • Rokh Kioung Khvan
RU2511417C2
DENDRITIC CELL GENERATION FROM MONOCYTIC DENDRITIC CELL PRE-CURSORS BY MEANS OF GM-CSF IN ABSENCE OF ADDITIONAL CYTOKINES 2004
  • Tdzhoa Bendzhamin A.
  • Bosh Marniks L.
RU2364625C2
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHOD FOR THEIR APPLICATION 2013
  • Flavell Richard A.
  • Mants Markus
  • Ronvo Entoni
  • Strovig Til
  • Villindzher Tim
  • Merfi Endryu Dzh.
  • Stivens Shon
  • Yankopulos Dzhordzh
RU2642319C2
METHOD OF MODIFICATION OF PERIPHERAL BLOOD MONOCYTES TO INCREASE THEIR PARACRINE ACTIVITY DURING AUTOLOGOUS TRANSPLANTATION 2012
  • Sazonov Aleksej Ehduardovich
  • Jur'Eva Ksenija Sergeevna
  • Khvorilova Ksenija Vladimirovna
  • Kremer Elena Ehduardovna
  • Ikkert Ol'Ga Pavlovna
  • Saltykova Irina Vladimirovna
RU2497947C1
GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHOD FOR THEIR USE 2013
  • Flavell, Richard, A.
  • Manz, Markus
  • Rongvaux, Anthony
  • Strowig, Till
  • Willinger, Tim
  • Murphy, Andrew J.
  • Stevens, Sean
  • Yancopoulos, George
RU2768282C2
HUMANISED MOUSE M-CSF 2012
  • Merfi Endrju Dzh.
  • Stivens Shon
  • Ratinam Chozhavendan
  • Ejnon Elizabet
  • Mants Markus
  • Flavell Richard
  • Jankopulos Dzhordzh D.
RU2577978C2
HUMANIZED M-CSF MICE 2020
  • Merfi, Endryu, Dzh.
  • Stivens, Shon
  • Ratinam, Chozhavendan
  • Ejnon, Elizabet
  • Mants, Markus
  • Flavell, Richard
  • Yankopulos, Dzhordzh, D.
RU2819731C2
METHOD OF OBTAINING CELLS OF MONOCYTE ORIGIN INDUCING TRANSPLANT ACCEPTANCE, METHOD OF OBTAINING PHARMACEUTICAL COMPOSITION SUPPRESSING TRANSPLANT REJECTION REACTION, CELLS OF MONOCYTE ORIGIN INDUCING TRANSPLANT ACCEPTANCE, CELL MEDICINE FOR TRANSPLANT ACCEPTANCE INDUCTION, PHARMACEUTICAL COMPOSITION SUPPRESSING TRANSPLANT REJECTION REACTION, APPLICATION OF CELLS INDUCING TRANSPLANT ACCEPTANCE (VERSIONS),METHOD OF OBTAINING AND/OR REPRODUCTION OF REGULATORY T-LYMPHOCYTE, HYBRIDOMA CELL LINE, ANTIBODY AND ANTIBODY APPLICATION 2003
  • Kremer Bernd Karl Fridrikh
  • Fendrikh Fred
  • Runke Maren
RU2370535C2

RU 2 333 243 C2

Authors

Kremer Bernd Karl Fridrikh

Fendrikh Fred

Runke Maren

Dates

2008-09-10Published

2003-03-28Filed